[Date Prev][Date Next][Date Index]

E-M:/ Journal devoted to corporate corruption of science

Title: Journal devoted to corporate corruption of science
This month's issue of the International Journal of Occupational and Environmental Health has an entire issue devoted to "corporate corruption of science' with case studies illustrating the point.  This follows on the American Journal of Public Health devoting an issue to some similar concerns.  Michigan industries are implicated in the case studies.

Note that this is a free full text online journal. See table of contents below.
To access the journal:  http://www.ijoeh.com/

This is from the online introduction:

"Although occupational and environmental diseases are often viewed as isolated and unique failures of science, the government, or industry to protect the best interest of the public, they are in fact an outcome of a pervasive system of corporate priority setting, decision making, and influence. This system produces disease because political, economic, regulatory and ideological norms prioritize values of wealth and profit over human health and environmental well-being. Science is a key part of this system; there is a substantial tradition of manipulation of evidence, data, and analysis, ultimately designed to maintain favorable conditions for industry at both material and ideological levels. This issue offers examples of how corporations influence science, shows the effects that influence has on environmental and occupational health, and provides evidence of a systemic problem."

IJOEH Vol. 11, No. 4 October-December, 2005
All articles are available as PDF files   at www.ijoeh.com

Corporate Corruption of Science
Guest Editor: David S. Egilman, MD, MPH, Susanna Rankin Bohme, AM
Over a Barrel: Corporate Corruption of Science and Its Effects on Workers and the Environment
David S. Egilman, MD, MPH, Susanna Rankin Bohme, AM
Industry Influence on Health and the Environment: Fantasy, Paranoia, Reality?
An Insider's Personal Experience
James Huff, PhD 
Maximizing Profit and Endangering Health: Corporate Strategies to Avoid Litigation and Regulation
Susanna Rankin Bohme, AM, John Zorabedian, David S. Egilman, MD, MPH
Lifting the Veil of Secrecy from Industry Funding of Nonprofit Health Organizations
Michael F. Jacobson, PhD
Business Bias: Or How an Increased Risk of Cancer and Other Diseases May Be Underestimated or Remain Undetected in Epidemiological Studies
Valerio Gennaro, MD, PhD, Lorenzo Tomatis, MD
Abuse of Epidemiology: The Automobile Manufacturers Manufacture a Defense to
Asbestos Liability
David S. Egilman, MD, MPH, Marion A. Billings
Safeguarding Scientific Evaluations of Governmental Agencies: A Case Study of
OSHA and 1,3-Butadiene
Peter Infante, DDS, DrPH
Industry Efforts to Weaken EPA Health Assessment of 1,3-Butadiene
Jennifer Beth Sass, PhD
Ethyl leaded gasoline:  How a Classic Occupational Disease Became an
International Public Health Disaster
William Kovarik, PhD  
Mining and Mendacity or How to Keep a Toxic Product in the Marketplace
Jock McCulloch, PhD
Fluoride Poisoning:  A Puzzle with Hidden Pieces
Phyllis J. Mullinex, PhD
The Dirty Work of "Recycling" America's Sewage Sludge
Caroline Snyder, PhD
Genetic Engineering in Agriculture and Corporate Engineering in Public
Debate: Risk, Public Relations, and Public Debate over Genetically Modified Crops
Rajeev Patel, MSc PhD, Robert J. Torres, MS, PhD, Peter Rosset, MSc, PhD
Who's Afraid of National Laws?: Pesticide Corporations Use Trade Negotiations
to Avoid Bans and Undercut Public Health Protections in Central America
Erika Rosenthal, JD, MSL
A Systemic Approach to Occupational and Environmental Health
Skip Spitzer, MA
Letter to the Editor
Response to Rothman and Arellano
David S. Egilman, MD, MPH, Susanna Rankin Bohme, AM